Strategic Planning

Antares Therapeutics Targets Rare Cancer Treatments with Precision
Care Antares Therapeutics Targets Rare Cancer Treatments with Precision

In today's intricate world of biotechnology, innovation often emerges from the transformation of existing knowledge and assets. Faisal Zain, a healthcare expert with deep roots in medical technology, joins us to discuss the significant establishment and aspirations of Antares Therapeutics

Job-Based Insurance: Reliable or Outdated for Americans?
Business Job-Based Insurance: Reliable or Outdated for Americans?

Is your health insurance as secure as your job? For many, the assumption that employment guarantees health coverage might seem straightforward. Surprisingly, even now, a staggering 60% of Americans under 65 rely on employer-sponsored insurance, underscoring its pivotal role in the healthcare

Redesigning Self-Funded Healthcare for Financial Stability
Business Redesigning Self-Funded Healthcare for Financial Stability

Self-funded healthcare models are grappling with mounting financial unpredictability, a prominent hurdle for employers managing health expenses in an evolving landscape. With healthcare costs surging annually and traditional risk strategies falling short, transformative approaches are emerging as

How Will CHCP Tackle Healthcare Staffing Shortages?
Workforce How Will CHCP Tackle Healthcare Staffing Shortages?

The persistent challenge of healthcare staffing shortages has plagued the medical industry, impacting the quality and accessibility of care. The College of Health Care Professions (CHCP), renowned for being the largest provider of allied health education in Texas, is addressing this crisis head-on.

B.C. Healthcare Crisis Demands Strategic Funding Reform
Public Policy B.C. Healthcare Crisis Demands Strategic Funding Reform

British Columbia's health-care system has been under significant scrutiny as residents increasingly voice their dissatisfaction with the prolonged wait times for medical services. Despite a substantial increase in healthcare spending, which saw a rise of $1.7 billion, bringing the projected

Is BMS's OncoACP3 Deal a Game-Changer for Prostate Cancer?
Care Is BMS's OncoACP3 Deal a Game-Changer for Prostate Cancer?

In the ever-evolving field of oncology, Bristol Myers Squibb has made waves with its strategic expansion into radiopharmaceuticals for prostate cancer. Leading this charge is the promising compound, OncoACP3, developed in collaboration with Philochem. Here to talk about these exciting developments

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later